Physician
Obstetrics & Gynecology
Dr. Abbie L. Fields, MD
|
|
Give Review
Dr. Abbie L. Fields practices Obstetrics & Gynecology. She studied medicine at The Ohio State University College of Medicine. She received 1 awards: "Fellow (FACS)". Dr. Abbie L. Fields is a published doctor and has 42 publications published. The lastest was: 'Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry.' She is registered with Medicare.
Publications
- Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous Carcinoma (UPSC).
- Efficacy and toxicity of concomitant cisplatin With external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally adva...
- Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced Cervical cancer.
- Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003).
- Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: a brief communication from the New York Phase II consortium.
- Evaluation of low-dose intraperitoneal interferon-alpha for palliation of ascites in patients With non-ovarian gynecologic malignancies.
- Extended-field radiotherapy and high-dose-rate brachytherapy in Carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
- Current therapies in ovarian Cancer.
- Two fractions of high-dose-rate brachytherapy in the management of cervix Cancer: clinical experience with and without chemotherapy.
- Retinol and postoperative colorectal Cancer patients.
- Chronic lactic acidosis in a patient with Cancer: therapy and metabolic consequences.
- Theoretical aspects of weight loss in patients with Cancer. Possible importance of pyruvate dehydrogenase.
- Chemotherapy in metastatic gastric Cancer: population-based perceptions and practice patterns of medical oncologists.
- Clinical survival predictors in patients with advanced Cancer.
- The genetics of ovarian Cancer: an assessment of current screening protocols and recommendations for counseling families at risk.
- Induction of transforming growth factor beta-1 in Cervical intraepithelial neoplasia in vivo after treatment with beta-carotene.
- Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal Cancer. A National Cancer Institute of Canada Clinical Trials Group Study.
- Phase II study of acivicin in colorectal Carcinoma: a National Cancer Institute of Canada study.
- Upstaging pathologic stage I ovarian Carcinoma based on dense adhesions is not warranted: a clinicopathologic study of 84 patients originally classified as FIGO stage II.
- Screening for gynecologic malignancies: A continuing responsibility.
- Outpatient 5-fluorouracil, folinic acid and cisplatin in patients with advanced esophageal Carcinoma.
- A safety study of a mixed-backbone oligonucleotide (GEM231) targeting the type I regulatory subunit alpha of protein kinase A using a continuous infusion schedule in p...
- Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry.
- Long-term follow-up of stage I cervical adenoCarcinoma treated by radical surgery.
- Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian Carcinomas.
- Profound thrombocytopenia in previously treated patients with recurrent ovarian Carcinoma receiving topotecan.
- How often should a port-A-cath be flushed?
- Squamous cell Carcinoma in mature cystic teratoma in a young woman: a diagnostic and management dilemma.
- Endometrioid adenoCarcinoma of the ovary and long-term tamoxifen therapy: a coincidence or a cause for concern?
- Compliance with Papanicolaou smear screening following tubal ligation in women with Cervical cancer.
- Continuous low-dose combined hormone replacement therapy and the risk of endometrial Cancer.
- Ovarian carcinoid: management of primary and recurrent tumors.
- Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of Uterine sarcomas.
- Allelotype of papillary serous peritoneal Carcinomas.
- A phase I safety and dose escalation trial of docetaxel combined With GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patie...
- Patterns of failure after the multimodality treatment of uterine papillary serous Carcinoma.
- Altered expression of transforming growth factor-beta 1 in Cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix.
- Promising new therapies in the treatment of advanced ovarian Cancer.
- Pelvic exenteration for cervix Cancer: would additional intraoperative interstitial brachytherapy improve survival?
- Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell Carcinoma of the cervix.
- Phase I clinical trial of parenteral hydroxyurea in combination With pelvic and para-aortic external radiation and brachytherapy for patients With advanced squamous ce...
Schools
Ohio State University College Of Medicine and Public Health
Northwestern Memorial Hospital
Prentice Womens HosMater
The Johns Hopkins Hospital
Procedures Preformed
- Colporrhaphy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Johns Hopkins University -
The Ohio State University College of Medicine
Drug Facts
| NPI NUMBER | 1811971898 | |
| NPPES Provider LastName | FIELDS | |
| NPPES Provider FirstName | ABBIE | |
| NPPES Provider ZIPCode | 212155228 | |
| NPPES Provider State | MD | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 114.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811971898 |
| Last Name Of The Provider | FIELDS |
| First Name Of The Provider | ABBIE |
| View All |
Similar Doctors
|
|
Dr. Catherine Spong, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Susan G. Smigocki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Israel Alter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James F. Barter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barry Aron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Zuckerman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jill J. Ladd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert J. Steren, MD
This Doctor is OpenDoctor Recommended.
|